We are live on ! Find out more
OM icon

Outset Medical

152 hedge funds and large institutions have $584M invested in Outset Medical in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.19M

0.02% more ownership

Funds ownership: 7.18%7.2% (+0.02%)

2% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 52

8% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 26

1% less funds holding

Funds holding: 154152 (-2)

50% less capital invested

Capital invested by funds: $1.16B → $584M (-$574M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
152
Holders Change
-2
Holders Change %
-1.3%
% of All Funds
2.41%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
24
Increased
51
Reduced
52
Closed
26
Calls
$1.32M
Puts
$1.19M
Net Calls
+$133K
Net Calls Change
-$219K
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$4.57M -$1.27M -5,367 -16%
Charles Schwab
27
Charles Schwab
California
$4.16M +$217K +921 +4%
Ensign Peak Advisors
28
Ensign Peak Advisors
Utah
$3.84M +$1.33M +5,628 +31%
NCGI
29
Next Century Growth Investors
Minnesota
$3.63M -$2.26M -9,596 -30%
N
30
Nuveen
North Carolina
$3.48M -$121K -513 -2%
Lazard Asset Management
31
Lazard Asset Management
New York
$2.4M +$477K +2,023 +16%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$2.3M -$3.54M -15,004 -52%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$1.83M +$2.12K +9 +0.1%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$1.58M -$1.2M -5,080 -34%
UBS AM
35
UBS AM
Illinois
$1.51M +$72.7K +308 +3%
PVI
36
Pura Vida Investments
New York
$1.5M -$6.37M -26,983 -75%
Bank of America
37
Bank of America
North Carolina
$1.44M -$1.49M -6,305 -42%
Tudor Investment Corp
38
Tudor Investment Corp
Connecticut
$1.35M +$1.96M +8,290 New
Renaissance Technologies
39
Renaissance Technologies
New York
$1.29M +$1.87M +7,933 New
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.12M +$101K +426 +7%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$1.01M
PP
42
PDT Partners
New York
$947K +$1.37M +5,804 New
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$933K -$405K -1,714 -23%
GCP
44
GSA Capital Partners
United Kingdom
$919K +$1.04M +4,388 +353%
HighTower Advisors
45
HighTower Advisors
Illinois
$916K +$390K +1,653 +42%
Voloridge Investment Management
46
Voloridge Investment Management
Florida
$897K -$968K -4,102 -43%
TI
47
Trexquant Investment
Connecticut
$858K +$646K +2,735 +109%
CSS
48
Cubist Systematic Strategies
Connecticut
$817K +$703K +2,979 +147%
Goldman Sachs
49
Goldman Sachs
New York
$816K -$444K -1,879 -27%
ORI
50
Oak Ridge Investments
Illinois
$739K -$21.5K -91 -2%

OM Hedge Fund Activity: Q3 2023 in Review

152 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2023, worth a combined $584M — down 50% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of OM and 24 opened new positions — a net loss of 2 holders — while 52 trimmed existing stakes and 51 added.

The largest buyer was Morgan Stanley, adding an estimated $16.5M. The largest seller was Bellevue Group, cutting an estimated $11.3M.

  • 152 institutional investors held Outset Medical (OM) as of Q3 2023, down from 154 in Q2 2023.
  • Funds reported $584M of Outset Medical stock for Q3 2023, down 50% quarter-over-quarter.
  • 24 funds opened new Outset Medical positions in Q3 2023 and 26 closed out, a net change of -2 holders.
  • The largest Outset Medical buyer in Q3 2023 was Morgan Stanley, an estimated $16.5M added.
  • The largest Outset Medical seller in Q3 2023 was Bellevue Group, an estimated $11.3M sold.

Based on aggregated 13F filings for Q3 2023.